Do we have a knowledge transfer and translation plan at Teratogen Information Services?

Reproductive Toxicology

Volumn 22, Issue 3, 2006, Pages 542-545

  Einarson, Adrienne ^a   Lockett, Donna ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Knowledge transfer translation; Pregnancy; Teratogen Information Services

Indexed keywords

ANTIDEPRESSANT AGENT; BENDECTIN; DOXYLAMINE; ISOTRETINOIN; PYRIDOXINE;

ARTICLE; BREAST FEEDING; CANADA; DECISION MAKING; DRUG SAFETY; FEMALE; FOOD AND DRUG ADMINISTRATION; HEALTH CARE QUALITY; HUMAN; NAUSEA AND VOMITING; NAUSEA AND VOMITING OF PREGNANCY; PATIENT COUNSELING; PREGNANT WOMAN; RISK BENEFIT ANALYSIS; RISK MANAGEMENT; TERATOGENICITY; UNITED STATES;

CANADA; DRUG INFORMATION SERVICES; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INFORMATION DISSEMINATION; TERATOGENS;

EID: 33748531871     PISSN: 08906238     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.reprotox.2006.02.002     Document Type: Article

References (27)

1. Leen-Mitchell M., Martinez L., Gallegos S., Robertson J., and Carey J.C. Mini-review: a history of organized Teratology Information Services in North America. Teratology 61 4 (2000) 314-317
2. Einarson A., Shuhaiber S., and Koren G. Effects of antibacterials on the unborn child: what is known and how should this influence prescribing. Paediatr Drugs 3 11 (2001) 803-816
3. Jones K.L., Johnson K.A., Dick L.M., Felix R.J., Kao K.K., and Chambers C.D. Pregnancy outcomes after first trimester exposure to phentermine/fenfluramine. Teratology 65 3 (2002) 125-130
4. Loebstein R., Addis A., Ho E., Andreou R., Sage S., Donnenfeld A.E., et al. Pregnancy outcomefollowing gestational exposure to fluoroquinolones: a multicenter, prospective controlled study. Antimicrob Agents Chemother 42 6 (1998) 1336-1339
5. Kulin N.A., Pastuszak A., Sage S.R., Schick-Boschetto B., Spivey G., Feldkamp M., et al. Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: a prospective controlled multicenter study. JAMA 279 8 (1998) 609-610
6. Einarson A., Fatoye B., Sarkar M., Lavigne S.V., Brochu J., Chambers C., et al. Pregnancy outcome following gestational exposure to venlafaxine: a multicenter prospective controlled study. Am J Psychiatry 158 10 (2001) 1728-1730
7. Bailey B., Addis A., Lee A., Sanghvi K., Mastroiacovo P., Mazzone T., et al. Cisapride use during human pregnancy: a prospective, controlled multicenter study. Dig Dis Sci 42 9 (1997) 1848-1852
8. Magee L.A., Schick B., Donnenfeld A.E., Sage S.R., Conover B., Cook L., et al. The safety of calcium channel blockers in human pregnancy: a prospective, multicenter cohort study. Am J Obstet Gynecol 174 3 (1996) 823-828
9. Pastuszak A.L., Levy M., Schick B., Zuber C., Feldkamp M., Gladstone J., et al. Outcome after maternal varicella infection in the first 20 weeks of pregnancy. N Engl J Med 330 13 (1994) 901-905
10. Chambers C.D., Braddock S.R., Briggs G.G., Einarson A., Johnson Y.R., Miller R.K., et al. Postmarketing surveillance for human teratogenicity: a model approach. Teratology 64 5 (2001) 252-261
11. Rynes SL, Bartunek JM, Daft RL. Across the great divide: knowledge creation and transfer between practioners and academics. Acad Manage J, in press.
12. Canadian Institute for Health Research (CIHR). Knowledge translation strategy 2004-2009: innovation in action. Canadian Institutes of Health Research, Ottawa, Ont., Canada; 2004. www.cihr-irsc.gc.ca/e/8505.html.
13. www.ahrq.gov/about/ockt/ocktmiss.htm
14. CHSRF. Canadian Health Services Research Foundation "is research working for you?. Ottawa, Ont., Canada; 2006. www.chsrf.ca.
15. Landry R, Lamari M, Amara N. Extent and determinants of utilization of university research in government agencies. Public Adm Rev, in press.
16. Lavis J.N., Robertson D., Woodside J.M., McLeod C.B., and Abelson J. How can research organizations more effectively transfer research knowledge to decision makers?. Milbank Q 81 2 (2003) 221-249
17. Lomas J. Connecting research and policy. Isuma 1 1 (2000) 140-144
18. Hardy B., Hudson B., and Waddington E. Partnership assessment tool: adult care (2003), Partnership Assessment Associates, UK
19. Barwick M., Boydell K., and Ferguson B. Using knowledge transfer to facilitate the adoption of evidence-based practice. Report poster presented at the 5th international conference on the scientific basis of health services: global evidence for local decision. Washington, DC, USA (2005)
20. Einarson T.R., Leeder J.S., and Koren G. A method for meta-analysis of epidemiological studies. Drug Intell Clin Pharm 22 October (10) (1988) 813-824
21. ® Compendium of Pharmaceuticals and Specialties (CPS). Ottawa, Canada; 2005.
22. Carver V., Coyle B., Koren G., Lavigne S., Martinez L., Robertson J., et al. A call for action-prevention of fetal exposure to isotretinoin A position paper by The Organization of Teratology Information Services Public Affairs Committee. Reprod Toxicol 15 November-December (6) (2001) 729
23. Brinker A., Kornegay C., and Nourjah P. Trends in adherence to a revised risk management program designed to decrease or eliminate isotretinoin-exposed pregnancies: evaluation of the accutane SMART program. Arch Dermatol 141 May (5) (2005) 563-569
24. Koren G. Maternal fetal toxicology (the decision to terminate a pregnancy) (2001), Marcel Dekker, New York, NY, USA p. 784-9
25. Bakhireva LN, Jones KL, Schatz M, Johnson D, Chambers CD, Organization of Teratology Information Services Research Group. Asthma medication use in pregnancy and fetal growth. J Allergy Clin Immunol 2005;116(September (3)):503-9.
26. Einarson A, Schachtschneider AK, Halil R, Bollano E, Koren G. SSRI'S and other antidepressant use during pregnancy and potential neonatal adverse effects: impact of a public health advisory and subsequent reports in the news media. BMC Pregnancy Childbirth 2005;5:11.
27. Baggley A., Navioz Y., Maltepe C., Koren G., and Einarson A. Determinants of women's decision making on whether to treat nausea and vomiting of pregnancy pharmacologically. J Midwifery Womens Health 49 July-August (4) (2004) 350-354